Indications of Duvelisib Capsules

Duvelisib capsules (Duvelisib) are anti-cancer drugs used for certain types of lymphoma. Its indications mainly include adult Tcell leukemia lymphoma/lymphoma cell leukemia (ATLL/CTCL) and relapsed small Bcell lymphoma. Here are details about these indications:

1.AdultTCell Leukemia Lymphoma/Lymphoma Cell Leukemia (ATLL/CTCL): This is a rare but serious blood cancer that originates from T cells. ATLLUsually manifests as skin lesions, swollen lymph nodes, organ damage, and symptoms of high-grade viral infection. CTCLis a skin-related lymphoma that usually presents with skin lesions, itching, and ulcers. Duvelisel is used to treat both diseases and can help slow the progression of the disease and improve patients' quality of life.

2.Relapsed smallBcell lymphoma: This includes various types of smallBcell lymphoma, such as chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL). Duveliced u200bu200bhas also shown certain efficacy in the treatment of these diseases. For patients with relapsed smallB cell lymphoma, duveliside may be a treatment option with the potential to slow the progression of the disease.

In short, duvelised capsules have indications for the treatment of adult Tcell leukemia lymphoma/lymphoma cell leukemia and relapsed small Bcell lymphoma. These diseases are often associated with abnormalities in the immune system and lymphocytes, and duveliside, as a targeted drug that can interfere with related biological processes, provides a promising treatment option. Patients should use duvelised under the guidance of a doctor and receive individualized treatment based on their specific conditions.

The original drug of Duvelisel Capsules has been launched in China, but it is not covered by medical insurance. Patients can buy it domestically at a price of more than 20,000 yuan. For specific prices, please consult the local hospital pharmacy.